Repurposing of medications for pulmonary arterial hypertension.

导出 OA

翻译打印收藏纠错

作者： Mark,Toshner ^[1] ; Edda,Spiekerkoetter ^[2] ; Harm,Bogaard ^[3] ; Georg,Hansmann ^[4] ; Sylvia,Nikkho ^[5] ; Kurt W,Prins ^[6]

作者单位： Department of Medicine, University of Cambridge, Cambridge, UK. ^[1] Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. ^[2] Department of Pulmonary Medicine, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. ^[3] Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany. ^[4] Bayer Pharmaceuticals, Clinical Development Pulmonology, Berlin, Germany. ^[5] Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA. ^[6]

关键词 drug repurposing preclinical studies pulmonary hypertension

DOI 10.1177/2045894020941494

PMID 33282182

发布时间 2024-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pulmonary circulation

2045894020941494页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Repurposing of medications for pulmonary arterial hypertension.

Pulmonary circulation

相似文献

Pulmonary circulation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Repurposing of medications for pulmonary arterial hypertension.

Pulmonary circulation

相似文献

Pulmonary circulation

相关期刊

检索历史清除